Health knowledge made personal
Join this community!
› Share page:
Search posts:

Gilead Issues A Voluntary Recall Of One Lot Of Vistide® (CIDOFOVIR INJECTION) Due To Presence Of Particulate Matter

Posted Feb 15 2013 9:25pm
Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is voluntarily recalling lot B120217A of Vistide® (cidofovir injection) to the user level due to the presence of particulate matter found in some vials of this lot.
Post a comment
Write a comment:

Related Searches